{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["B cells", "Brd4", "JQ1", "Oct2", "bromo and extraterminal domains", "epigenetic gene regulation", "histone modifications", "immunoglobulin"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28322577", "DateCompleted": {"Year": "2017", "Month": "10", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "29"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "03", "Day": "21"}], "ELocationID": ["10.2217/epi-2016-0147"], "Journal": {"ISSN": "1750-192X", "JournalIssue": {"Volume": "9", "Issue": "4", "PubDate": {"Year": "2017", "Month": "Apr"}}, "Title": "Epigenomics", "ISOAbbreviation": "Epigenomics"}, "ArticleTitle": "BET proteins are a key component of immunoglobulin gene expression.", "Pagination": {"StartPage": "393", "EndPage": "406", "MedlinePgn": "393-406"}, "Abstract": {"AbstractText": ["BET proteins have been shown to regulate gene expression including inflammatory genes.", "In order to investigate the role of the BET proteins in immunoglobulin production we treated the human B-cell line CLNH11.4 and primary human B cells and ozone-exposed mice with BET inhibitors (JQ1 or IBET151).", "Both proliferation and IgG production were reduced by JQ1 in a concentration-dependent manner. JQ1 significantly reduced immunoglobulin gene transcription. In vivo treatment of ozone-exposed mice with the BET inhibitor IBET151 similarly inhibited ozone-induced immunoglobulin production. JQ1 did not reduce the protein levels of Brd4 or Oct2 per se but reduced the ability of Brd4 and Oct2 to co-immunoprecipitate and of Oct2 to bind to immunoglobulin gene promoters.", "Our results indicate that BET proteins including Brd4 play a crucial role regulation B-cell-specific gene expression and immunoglobulin production."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Shim", "ForeName": "Jung Min", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Lee", "ForeName": "Jin S", "Initials": "JS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Russell", "ForeName": "Kirsty E", "Initials": "KE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Wiegman", "ForeName": "Coen H", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Barnes", "ForeName": "Peter J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, Department of Respiratory Medicine & Allergy, King's College London, London, WC2R 2LS, UK."}], "LastName": "Fear", "ForeName": "David", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Adcock", "ForeName": "Ian M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, SW7 2AZ, UK."}], "LastName": "Durham", "ForeName": "Andrew L", "Initials": "AL"}], "GrantList": [{"GrantID": "G0801266", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "G1000758", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Epigenomics", "NlmUniqueID": "101519720", "ISSNLinking": "1750-192X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "(+)-JQ1 compound"}, {"RegistryNumber": "0", "NameOfSubstance": "Azepines"}, {"RegistryNumber": "0", "NameOfSubstance": "BRD4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cell Cycle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "GSK1210151A"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, 4 or More Rings"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin G"}, {"RegistryNumber": "0", "NameOfSubstance": "Nuclear Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Organic Cation Transport Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Organic Cation Transporter 2"}, {"RegistryNumber": "0", "NameOfSubstance": "SLC22A2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazoles"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Azepines"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "B-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Cell Cycle Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Epigenesis, Genetic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Heterocyclic Compounds, 4 or More Rings"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Immunoglobulin G"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nuclear Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Organic Cation Transport Proteins"}, {"QualifierName": [], "DescriptorName": "Organic Cation Transporter 2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factors"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Triazoles"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kindt TJ, Golsby RA, Osborne BA, editors. Kuby Immunology. WH Freeman and Company; NY, USA: 2007."}, {"Citation": "Hozumi N, Tonegawa S. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci USA. 1976;73(10):3628\u20133632. [\u2022 Develops some of the important early evidence for the mechanisms that underpin immunoglobulin gene rearrangement.]", "ArticleIdList": ["PMC431171", "824647"]}, {"Citation": "Steiner G, Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res Ther. 2002;4(2):S1\u2013S5.", "ArticleIdList": ["PMC3238219", "12110150"]}, {"Citation": "Sawalha AH, Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol. 2004;16(5):534\u2013540.", "ArticleIdList": ["15314490"]}, {"Citation": "Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med. 1995;152(6):1753\u20131756.", "ArticleIdList": ["8520733"]}, {"Citation": "Kirkham PA, Caramori G, Casolari P, et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(7):796\u2013802.", "ArticleIdList": ["PMC3398415", "21965015"]}, {"Citation": "Pelletier MR, Hatada EN, Scholz G, Scheidereit C. Efficient transcription of an immunoglobulin \u03ba promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site. Nucleic Acids Res. 1997;25(20):3995\u20134003.", "ArticleIdList": ["PMC147016", "9321649"]}, {"Citation": "Hodson DJ, Shaffer AL, Xiao W, et al. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc Natl Acad Sci USA. 2016;113(14):E2039\u2013E2046.", "ArticleIdList": ["PMC4833274", "26993806"]}, {"Citation": "Saez AI, Artiga MJ, Sanchez-Beato M, et al. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas. Mod Pathol. 2002;15(3):211\u2013220.", "ArticleIdList": ["11904338"]}, {"Citation": "Porton B, Zaller DM, Lieberson R, Eckhardt LA. Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line. Mol Cell Biol. 1990;10(3):1076\u20131083.", "ArticleIdList": ["PMC360970", "2106067"]}, {"Citation": "Inlay MA, Lin T, Gao HH, Xu Y. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci. J Exp Med. 2006;203(7):1721\u20131732.", "ArticleIdList": ["PMC2118354", "16785310"]}, {"Citation": "Durham A, Chou PC, Kirkham P, Adcock IM. Epigenetics in asthma and other inflammatory lung diseases. Epigenomics. 2010;2(4):523\u2013537.", "ArticleIdList": ["22121972"]}, {"Citation": "Xu CR, Feeney AJ. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling. J Immunol. 2009;182(3):1362\u20131369.", "ArticleIdList": ["PMC2804480", "19155482"]}, {"Citation": "Bergman Y, Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immunol. 2004;4(10):753\u2013761.", "ArticleIdList": ["15459667"]}, {"Citation": "Kondilis-Mangum HD, Wade PA. Epigenetics and the adaptive immune response. Mol Aspects Med. 2013;34(4):813\u2013825.", "ArticleIdList": ["PMC3508324", "22789989"]}, {"Citation": "Berkovits BD, Wolgemuth DJ. The role of the double bromodomain-containing BET genes during mammalian spermatogenesis (Chapter 11) In: Paul MW, editor. Current Topics in Developmental Biology. Academic Press; 2013. pp. 293\u2013326.", "ArticleIdList": ["PMC3918955", "23287038"]}, {"Citation": "Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 Is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005;19(4):523\u2013534. [\u2022 While previously it was known that Brd4 bound to chromatin and acted as a histone code reader, this article identified the key role Brd4 plays in transcriptional elongation in many genes.]", "ArticleIdList": ["16109376"]}, {"Citation": "Jung M, Philpott M, M\u00fcller S, et al. Affinity Map of BRD4 interactions with the histone H4 tail and the small molecule inhibitor JQ1. J Biol Chem. 2014;289(13):9304\u20139319.", "ArticleIdList": ["PMC3979416", "24497639"]}, {"Citation": "Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468(7327):1067\u20131073. [\u2022 Reports the development of the small molecule BET inhibitor JQ1.]", "ArticleIdList": ["PMC3010259", "20871596"]}, {"Citation": "Donato E, Croci O, Sabo A, et al. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia. 2016;31(2):479\u2013490.", "ArticleIdList": ["PMC5310924", "27443262"]}, {"Citation": "Durham AL, Mclaren A, Hayes BP, et al. Regulation of Wnt4 in chronic obstructive pulmonary disease. FASEB J. 2013;27(6):2367\u20132381.", "ArticleIdList": ["PMC3659349", "23463699"]}, {"Citation": "Low TB, Greene CM, O\u2019neill SJ, Mcelvaney NG. Quantification and evaluation of the role of antielastin autoantibodies in the emphysematous lung. Pulm Med. 2011;2011:826160.", "ArticleIdList": ["PMC3109555", "21660246"]}, {"Citation": "Pastori C, Daniel M, Penas C, et al. BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics. 2014;9(4):611\u2013620.", "ArticleIdList": ["PMC4121371", "24496381"]}, {"Citation": "Okamura D, Maeda I, Taniguchi H, et al. Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells. Genes Dev. 2012;26(22):2477\u20132482.", "ArticleIdList": ["PMC3505818", "23154982"]}, {"Citation": "Dey A, Nishiyama A, Karpova T, Mcnally J, Ozato K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell. 2009;20(23):4899\u20134909.", "ArticleIdList": ["PMC2785733", "19812244"]}, {"Citation": "Zhang W, Prakash C, Sum C, et al. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012;287(51):43137\u201343155.", "ArticleIdList": ["PMC3522308", "23086925"]}, {"Citation": "Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol. 2013;190(7):3670\u20133678.", "ArticleIdList": ["PMC3608815", "23420887"]}, {"Citation": "Tang X, Peng R, Phillips JE, et al. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. Am J Pathol. 2013;183(2):470\u2013479.", "ArticleIdList": ["23759512"]}, {"Citation": "Wienerroither S, Rauch I, Rosebrock F, et al. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins. Mol Cell Biol. 2014;34(3):415\u2013427.", "ArticleIdList": ["PMC3911514", "24248598"]}, {"Citation": "Sepulveda MA, Emelyanov AV, Birshtein BK. NF-\u03baB and Oct-2 synergize to activate the human 3\u2032 Igh hs4 enhancer in B Cells. J Immunol. 2004;172(2):1054\u20131064.", "ArticleIdList": ["14707079"]}, {"Citation": "Zeng L, Zhou MM. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002;513(1):124\u2013128.", "ArticleIdList": ["11911891"]}, {"Citation": "Wu SY, Chiang CM. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem. 2007;282(18):13141\u201313145.", "ArticleIdList": ["17329240"]}, {"Citation": "Rahman S, Sowa ME, Ottinger M, et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol. 2011;31(13):2641\u20132652.", "ArticleIdList": ["PMC3133372", "21555454"]}, {"Citation": "Yang Z, Yik JHN, Chen R, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005;19(4):535\u2013545.", "ArticleIdList": ["16109377"]}, {"Citation": "Maruyama T, Farina A, Dey A, et al. A mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol. 2002;22(18):6509\u20136520.", "ArticleIdList": ["PMC135621", "12192049"]}, {"Citation": "Farina A, Hattori M, Qin J, Nakatani Y, Minato N, Ozato K. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating Its activity and subcellular localization. Mol Cell Biol. 2004;24(20):9059\u20139069.", "ArticleIdList": ["PMC517877", "15456879"]}, {"Citation": "Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. Brd4 coactivates transcriptional activation of NF-\u03baB via specific binding to acetylated RelA. Mol Cell Biol. 2009;29(5):1375\u20131387.", "ArticleIdList": ["PMC2643823", "19103749"]}, {"Citation": "Wu SY, Lee AY, Hou SY, et al. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 2006;20(17):2383\u20132396.", "ArticleIdList": ["PMC1560413", "16921027"]}, {"Citation": "Ahmad I, Hoessli DC, Walker-Nasir E, Rafik SM, Shakoori AR, Nasir-Ud-Din Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation. Nucleic Acids Res. 2006;34(1):175\u2013184.", "ArticleIdList": ["PMC1326018", "16431844"]}, {"Citation": "Zwilling S, Annweiler A, Wirth T. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res. 1994;22(9):1655\u20131662.", "ArticleIdList": ["PMC308045", "8202368"]}, {"Citation": "Deeney JT, Belkina AC, Shirihai OS, Corkey BE, Denis GV. BET bromodomain proteins Brd2, Brd3 and Brd4 selectively regulate metabolic pathways in the pancreatic beta-cell. PLoS ONE. 2016;11(3):e0151329.", "ArticleIdList": ["PMC4805167", "27008626"]}], "ReferenceList": []}], "History": [{"Year": "2017", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28322577", "EMS73044", "PMC5476213", "10.2217/epi-2016-0147"]}}], "PubmedBookArticle": []}